OnKure Therapeutics, Inc.
OKUR
$3.99
$0.092.31%
NASDAQ
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 9.72% | 14.77% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 8.22% | 10.55% | |||
| Operating Income | -8.22% | -10.55% | |||
| Income Before Tax | -1.25% | -12.25% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -1.25% | -12.25% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -1.25% | -12.25% | |||
| EBIT | -8.22% | -10.55% | |||
| EBITDA | -8.39% | -10.63% | |||
| EPS Basic | 72.24% | -11.61% | |||
| Normalized Basic EPS | 72.24% | -11.62% | |||
| EPS Diluted | 72.24% | -11.61% | |||
| Normalized Diluted EPS | 72.24% | -11.62% | |||
| Average Basic Shares Outstanding | 264.68% | 0.57% | |||
| Average Diluted Shares Outstanding | 264.68% | 0.57% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||